To the best of our knowledge, to date, there has been no study on the direct associations between CIMT and the relevant atherosclerosis markers particularly ICAM-1 and Lp(a) in patients with OSA and ultrasound- proven NAFLD. Here, ICAM1 is linked to metabolic dysfunction-associated steatotic liver disease.